20
Nov
2009
Posted in I - Series A, Q - 4Q09, R - INTERNATIONAL, X - Device (Breathing), X - Device (Delivery)
Activaero (Germany) a commercial-stage medical device company focused on patient-tailored controlled breathing and inhaled therapeutic delivery systems, closed a $15.9M Series A financing. Participants include BioMedPartners, VI Partners, Abalis Finance and Vesalius Biocapital.